STRATA Skin Sciences

71 articles about STRATA Skin Sciences

• STRATA Skin Sciences Announces Acquisition of Acne Treatment Device Assets from Theravant Corporation

  1/10/2022

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that it has entered into a definitive agreement to acquire assets related to Theravant Corporation’s TheraClear System.

• STRATA Skin Sciences to Present at the H.C. Wainwright Bioconnect Virtual Conference

  12/27/2021

  STRATA Skin Sciences, Inc. today announced that members of Management will participate in the upcoming H.C. Wainwright Bioconnect Virtual Conference.

• STRATA Skin Sciences Announces Board of Directors Transition

  12/9/2021

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that Douglas Strang was appointed to the Board of Directors, effective October 27, 2021.

• STRATA Skin Sciences Reports Third Quarter 2021 Financial Results

  11/10/2021

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced financial results for the quarter ended September 30, 2021.

• STRATA Skin Sciences to Report Third Quarter 2021 Financial Results on November 10, 2021

  10/27/2021

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that it plans to release its third quarter 2021 financial results after the market closes on Wednesday, November 10, 2021.

• 

  BioSpace Movers & Shakers, Oct. 8

  10/8/2021

  Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

• STRATA Skin Sciences Announces CFO Transition

  10/4/2021

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announced that Mr. Christopher Lesovitz, STRATA's current Controller, has been named Chief Financial officer.

• STRATA Skin Sciences to Participate in Upcoming Investor Conferences in September 2021

  9/2/2021

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announced the Company will participate in two upcoming investor conferences.

• Ra Medical Systems Announces Sale of Pharos Dermatology Business

  8/16/2021

  Ra Medical Systems, Inc., a medical device company focused on commercializing its excimer laser system to treat vascular disease, announces the sale of its Pharos dermatology business to STRATA Skin Sciences for $3.7 million in cash.

• STRATA Skin Sciences Reports Second Quarter 2021 Financial Results

  8/16/2021

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announced financial results for the quarter ended June 30, 2021.

• STRATA Skin Sciences Announces Acquisition of the U.S. Dermatology Business of Ra Medical Systems

  8/16/2021

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announced the acquisition of the U.S. dermatology business of Ra Medical.

• STRATA Skin Sciences to Participate in the Oppenheimer MedTech, Tools & Diagnostics Summit

  5/18/2021

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced the Company will participate in the upcoming Oppenheimer MedTech, Tools & Diagnostics Summit.

• STRATA Skin Sciences Reports First Quarter 2021 Financial Results

  5/12/2021

  STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the quarter ended March 31, 2021.

• STRATA Skin Sciences to Report First Quarter 2021 Financial Results on May 12, 2021

  4/28/2021

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announced that it plans to release its first quarter 2021 financial results after the market closes on Wednesday, May 12, 2021.

• STRATA Skin Sciences Appoints William D. Humphries to Its Board of Directors

  4/12/2021

  STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the appointment of William D. Humphries to its Board of Directors.

• STRATA Skin Sciences Reports Fourth Quarter and Full Year 2020 Financial Results

  3/24/2021

  STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the quarter and full year ended December 31, 2020.

• STRATA Skin Sciences to Present at the Lytham Partners Spring 2021 Investor Conference

  3/16/2021

  STRATA Skin Sciences, Inc. (“STRATA”) (NASDAQ: SSKN), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that the company will participate in the upcoming Lytham Partners Spring 2021 Investor Conference.

• STRATA Skin Sciences Announces Independent Study Published in the Journal of The European Academy of Dermatology and Venereology

  3/15/2021

  STRATA Skin Sciences, Inc. (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the publication of an independent study on the treatment of vitiligo using the Company’s XTRAC excimer laser

• STRATA Skin Sciences to Report Fourth Quarter and Full Year 2020 Financial Results on March 24, 2021

  3/10/2021

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that it plans to release its fourth quarter and full year financial results after the market closes on Wednesday, March 24, 2021.

• STRATA Skin Sciences Announces Expanded Distribution Agreement in China with Wuhan Miracle Laser Systems, Inc.New Agreement Expands STRATA's Global Reach and Brings Successful Recurring Revenue Model to the Chinese Dermatology Market

  3/9/2021

  STRATA Skin Sciences, Inc., a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced an expanded direct distribution agreement with Wuhan Miracle Laser Systems, Inc., that provides for both recurring revenues from placements and direct capital from sales in China.